Technologies, Tools and Systems for Rethinking the Food of Today and Inventing the Tastes of the Future

Daniel Cermeno

Novel fabrication strategies by using additive manufacturing systems have revolutionized important industry sectors thanks to their ability to create objects, constructs and ultimately products. Due to the advantages of functionalization, customization, personalized nutrition design, simplified supply chain and broadening existing food materials, 3D printing has been extensively studied in the food sector during the past decade. While more applications, formats, and end-products are getting explored, the availability of industrial printer models and tool-sets that cover the necesities of the food printing processes are developed.

In this sense, the customization of the printing systems is a key factor in order to achieve optimized workflows, which allow to control important parameters such as the temperature, flow of the materials, combination of formulas, printing surfaces and fabrication speeds. These technologies have the potential to benefit a wide range of applications including personalized nutrition, author cusine, food texturing and specialized nourishment for people with digestive problems. Finally, the lessons learnt from the fields of biomedical research and regenerative medicine can set the basis for exploring new types of products based on animal cells and proteins by the time they also open new insights on the systems and processes needed for scaling up and regulatory approvals.

A presentation by Daniel Cermeño, Business Development and Application Specialist at REGEMAT 3D.


Question 1: What drives you?
Science and innovation applied for the development of new technologies that can create positive impacts in society.

Question 2: Why should the delegate attend your presentation?
To understand firsthand the types of tools and 3d printing systems that can be readily used for food manufacturing.

Question 3: What emerging technologies/trends do you see as having the greatest potential in the short and long run?
Synthetic biology, personalized solutions in nutrition and medicine, and sustainable technologies that can be scaled being harmless to the planet.

Question 4: What are the barriers that might stand in the way?
Costs, psychological acceptance, market distribution.

About Daniel Cemeno
Daniel Cermeño. Graduated in Biotechnology from the European University of Madrid. Postgraduate in Bioengineering and Business Management from the University of California, Riverside. After graduation, he started working as a research associate specialised in stem cells and regenerative medicine at 2 world-renowned laboratories at the University of California, San Diego. Then he moved to the UK where he completed his master’s studies at “King’s College, London” to specialise in marketing strategies for advanced therapies and regenerative medicine.

During this time, he combined his studies with the creation as co-founder and scientific director of the science-technology-based company “HigherSteaks Ltd.” in collaboration with the business startup accelerator program “Entrepreneur First”. After that, he began to hold the position of laboratory manager at the Tissue Engineering and 3D Printing Platform located at Hospital La Paz in Madrid. Currently, he transfers his technical and management knowledge to the business development of the leading bioprinting company REGEMAT 3D, through industrial alliances, commercialisation channels, as well as the design and execution of projects.

REGEMAT 3D is a world leading biotechnology company in the field of additive manufacturing with applications in biomedicine. The company manufactures systems and products covering a wide range of state-of-the-art bioprinting tools, and biomaterials, which are designed and created in a personalized fashion to meet with the specific needs of each research team and application.

Currently with presence in more than 30 countries, where it has validated its technology in several areas including skin bioprinting, cartilage regeneration, development of bioprinted analogues of cardiac tissue, and patient-specific disease models of cancer. In its value proposition, versatility, commitment and customization are included as fundamental pillars of the REGEMAT 3D work philosophy. For this reason, each of the users is considered as direct collaborators in the development of clinical and research solutions, based on advanced bioprinting technologies. A specific application requires unique solutions. Therefore, completely modular systems are developed that allow adaptation to the needs of each application area and of each particular research group.

Daniel Cemeno is speaker at the 2021 edition of 3D Food Printing Conference.

Leave a Reply